GCAC
AGN

Guardian Capital Advisors (Canada)’s Allergan plc AGN Stock Holding History

Guardian Capital Advisors (Canada)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,550
Closed -$668K – 173
2017
Q3 		$668K Hold
3,550
– – 0.09% 101
2017
Q2 		$867K Sell
3,550
-125
-3% -$29.4K 0.12% 100
2017
Q1 		$876K Buy
3,675
+550
+18% +$128K 0.13% 101
2016
Q4 		$690K Buy
+3,125
New +$647K 0.1% 110

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Guardian Capital Advisors (Canada)'s AGN Position: Q4 2017 in Review

Guardian Capital Advisors (Canada) sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 3,550 shares — an estimated $668K sold.

Guardian Capital Advisors (Canada) first reported a position in AGN in Q4 2016 and held it in 4 quarters. The position peaked at $876K in Q1 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Guardian Capital Advisors (Canada) reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Guardian Capital Advisors (Canada) sold 3,550 Allergan plc shares in Q4 2017, an estimated $668K.
  • Guardian Capital Advisors (Canada) first reported a position in Allergan plc in Q4 2016 and held it in 4 quarters.
  • Guardian Capital Advisors (Canada)'s Allergan plc position peaked at $876K in Q1 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q4 2017, filed 14 Feb 2018.